Results 11 to 20 of about 2,541 (178)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran

Journal of Tehran University Heart Center, 2023
Background: The present study aimed to determine the cost-effectiveness of ticagrelor compared with clopidogrel in Iranian patients with acute coronary syndrome (ACS).
Amir Hashemi-meshkini, Amirmohammad Tajik, Nayyereh Ayati, Shekoufeh Nikfar, Reza Koochak, Saeed Yaghoubifard, Azam Abbasi, Mehdi Varmaghani   +7 more
doaj   +1 more source

Experience and perspectives of distance learning of pharmacists-interns in the system of continuous education

Фармацевтичний журнал, 2019
Modernization of the educational process at the postgraduate stage using modern computer technologies is extremely urgent. The purpose of the study was to analyze the experience of distance learning of pharmacists-interns at the department of ...
Ya. O. Grynkiv, O. М. Zaliska, O. E. Sichkoriz   +2 more
doaj   +1 more source

Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions

Pharmacy in practice, 2021
In the past years, several factors such as evidence-based healthcare culture, quality-linked incentives, and patient-centered actions, associated with an important increase of financial constraints and pressures on healthcare budgets, resulted in a ...
F. Tonin, I. Aznar-Lou, V. Pontinha, R. Pontarolo, F. Fernandez‐Llimos   +4 more
semanticscholar   +1 more source

The role of pharmacoeconomics in current Indian healthcare system

Journal of Research in Pharmacy Practice, 2013
Phamacoeconomics can aid the policy makers and the healthcare providers in decision making in evaluating the affordability of and access to rational drug use.
Akram Ahmad, Isha Patel, Sundararajan Parimilakrishnan, Guru Prasad Mohanta, HaeChung Chung, Jongwha Chang   +5 more
doaj   +1 more source

Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey

BMJ Open, 2020
Objective The prevalence of diabetes in Vietnam has increased from 2.5% in 2007 to 5.5% in 2017, but the burden of direct non-medical and indirect costs is unknown.
Thi Tuyet Mai Kieu, Hong Nhung Trinh, Huy Tuan Kiet Pham, Thanh Binh Nguyen, Junice Yi Siu Ng   +4 more
doaj   +1 more source

Pharmacoeconomics and Health Economics in Drug Policy: A Systematic Review of Cost-Effectiveness and Budget Impact Analyses

Prospects in Pharmaceutical Sciences
Increasing healthcare expenditures, aging population, prevalence of chronic diseases and high-cost pharmaceutical innovations have made efficient use of resources in healthcare systems mandatory.
Mehmet Ali Yüzbaşıoğlu
semanticscholar   +1 more source

Utilizing Biosimilars to Help Increase Patients Access and Minimize the Financial Burden of Health Care System in Egypt

Bulletin of Faculty of Pharmacy Cairo University
Background: Biologics have provided enhanced clinical advantages, but at expense of enormous expenditures. The exorbitant expense of biologics was somewhat mitigated by the development of biosimilars.
Doaa M. Abd-El-Rady, Iman A. El-Baraky, Samar F. Farid   +2 more
doaj   +1 more source

A Brief Review of Pharmacoeconomics and Its Importance in Healthcare

Journal of Pharmaceutical Technology Research and Management
Background: Assessing health interventions today requires the use of economic knowledge due to the growing complexity and high cost of healthcare. Pharmacoeconomics, a branch of health economics, assesses the value of pharmaceutical goods and services by
Arti Saini, Shivam Sharma
semanticscholar   +1 more source

A cross – Sectional observational study on Pharmacoeconomics burden of COVID -19 in Ashmoun fever hospital Delta Egypt

Bulletin of Faculty of Pharmacy Cairo University
Background: A wide range of respiratory illnesses like common colds, Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) are caused by coronaviruses. In 2019 scientists in Wuhan, China discovered a new coronavirus (COVID-
Marwa Helmi Desouki, Marwa G. Elhennawy, Samar F. Farid   +2 more
doaj   +1 more source

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis

Health Research Policy and Systems, 2021
Background Over the past three decades, allocation of foreign currency subsidies has been the primary strategy of various administrations in Iran to improve access to medicines.
Alireza Olyaaeemanesh, Ebrahim Jaafaripooyan, Akbar Abdollahiasl, Majid Davari, Seyyed Meysam Mousavi, Mansoor Delpasand   +5 more
doaj   +1 more source